Literature DB >> 14622713

Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A.

Brian Freund1, Marvin Schwartz.   

Abstract

Botulinum toxin A has demonstrated efficacy in relieving pain in spastic and nonspastic muscle conditions. This analgesic property has generally been attributed to muscular relaxation. This study demonstrates initial muscular relaxation and concomitant pain relief in a masticatory muscle model. However, as muscle power returns to normal, pain relief is still very evident. This result suggests that the analgesic effect attributed to botulinum toxin is more complex than simple muscular relaxation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622713     DOI: 10.1054/jpai.2003.435

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  17 in total

Review 1.  Botulinum toxin treatment of myofascial pain: a critical review of the literature.

Authors:  Robert Gerwin
Journal:  Curr Pain Headache Rep       Date:  2012-10

2.  Botulinum toxin therapy for osteoarticular pain: an evidence-based review.

Authors:  Jasvinder A Singh
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-04-01       Impact factor: 5.346

3.  Application of botulinum toxin in pain management.

Authors:  Woo Seog Sim
Journal:  Korean J Pain       Date:  2011-02-25

Review 4.  Botulinum neurotoxin for pain management: insights from animal models.

Authors:  Flaminia Pavone; Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2010-12-21       Impact factor: 4.546

Review 5.  Botulinum Toxin for Neuropathic Pain: A Review of the Literature.

Authors:  Hyun-Mi Oh; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2015-08-14       Impact factor: 4.546

Review 6.  Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception.

Authors:  Dong-Wan Kim; Sun-Kyung Lee; Joohong Ahnn
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

7.  Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial.

Authors:  Shu-Fen Sun; Chien-Wei Hsu; Huey-Shyan Lin; Yi-Jiun Chou; Jun-Yang Chen; Jue-Long Wang
Journal:  J Foot Ankle Res       Date:  2014-02-06       Impact factor: 2.303

Review 8.  Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.

Authors:  Siro Luvisetto; Parisa Gazerani; Carlo Cianchetti; Flaminia Pavone
Journal:  Toxins (Basel)       Date:  2015-09-23       Impact factor: 4.546

9.  Botulinum toxin type A with or without needle electromyographic guidance in patients with cervical dystonia.

Authors:  Chuanjie Wu; Fang Xue; Wansheng Chang; Yajun Lian; Yake Zheng; Nanchang Xie; Lu Zhang; Chen Chen
Journal:  Springerplus       Date:  2016-08-08

10.  Incidental Treatment of a Subclinical Chronic Tension-Type Headache by Cosmetic Use of Botulinum Toxin A: A Case Report.

Authors:  Iselin Saltvig; Steen Henrik Matzen
Journal:  Case Rep Dermatol       Date:  2017-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.